MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Epidemiology worldwide.

Home SERVICES Questionnaire Licensing Our Catalog ITSQ (Insulin Treatment Satisfaction Questionnaire)


Developed by:
Novo Nordisk (Denmark)

Objective:
To measure diabetes treatment satisfaction, applicable to a wide range of diabetes therapies.

Copyright:
Copyright © Novo Nordisk, 2004. All rights reserved.

Reference publication:
Anderson RT, Skoylund SE, Marrero D, Levine DW, Meadows K, Brod M, Balkrishnan R. Development and validation of the insulin treatment satisfaction questionnaire. Clin Ther. 2004 Apr ;26(4) :565-78.


Conditions of use:

1. User Agreement:

User is required to complete and sign a User Agreement in which specific conditions requested by the Author are detailed.

2. Access fees:

carre6 Author's royalty fee: the use of the ITSQ in commercial studies is subject to Novo Nordisk royalty fees, of an amount of 500 €* per study and per language version requested.

Other specific conditions requested by the author are detailed in the User Agreement.

carre6 Distribution fees are requested according to the study design and context of use of the questionnaire:

  1. In not-funded academic research (1) and individual clinical practice: free of charge
  2. In funded academic research (2): 300 €* per study + an additional 50 €* per language version requested.
  3. In commercial studies (3) involving "for-profit" organizations: 600 €* per study + an additional 250 €* per language version requested.


* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies).

 

 

Review copy:

US English version available for review purpose only. Please click here to access.

 

 

Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73

This e-mail address is being protected from spambots. You need JavaScript enabled to view it

Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on the ITSQ on PROQOLID

[ BACK ]

 

2012 05 18

To access our catalog, please click here.

 

New questionnaires distributed by MAPI Research Trust

ACCEPT (Chronic Treatment Acceptance Questionnaire)
Registrat MAPI (France) and MAPI Consultancy

ADRQL (Alzheimer Disease Related Quality of Life)
Black Betty S, Kasper Judith D and Rabins Peter V. - Johns Hopkins Medical INstitutions (USA)

Barthel Index
Florence I. Mahoney and Dorothea W. Barthel.

ESS (Epworth Sleepiness Scale)
Murray W. Johns (Australia)

FIRST (Fibromyalgia Rapid Screening Tool)
Serge Perrot & Didier Bouhassira (France)

PDSS-2 (Parkinson's Disease Sleep Scale)
Ray Chaudhuri (UK), Claudia Trenkwalder (Germany), Ralf Kohnen (Germany)

Skindex questionnaire 
Mary-Margaret Chren (USA)

TRIM-D and TRIM-D Device (Treatment Related Impact Measure for Diabetes)
Novo Nordisk (Denmark)